Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Liver cancer resists most chemo drugs. The liver cancer drugs that have been most effective as systemic chemo in liver cancer are doxorubicin (Adriamycin), 5-fluorouracil, and cisplatin. But even these drugs shrink only a small portion of tumors, and the responses often do not last long.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Liver Cancer Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Liver Cancer Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Liver Cancer Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Exelixis
Bristol-Myers Squibb
Bayer
Eisai
Merck
By Type:
Targeted Therapy
Immunotherapy
By End-User:
Hospital
Home
Research
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Liver Cancer Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Liver Cancer Drugs Market Size and Growth Rate of Targeted Therapy from 2016 to 2027
-
1.3.2 China Liver Cancer Drugs Market Size and Growth Rate of Immunotherapy from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Liver Cancer Drugs Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Liver Cancer Drugs Market Size and Growth Rate of Home from 2016 to 2027
-
1.4.3 China Liver Cancer Drugs Market Size and Growth Rate of Research from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Liver Cancer Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Liver Cancer Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Targeted Therapy
-
3.4.2 Market Size and Growth Rate of Immunotherapy
4 Segmentation of Liver Cancer Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Liver Cancer Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Liver Cancer Drugs in Hospital
-
4.4.2 Market Size and Growth Rate of Liver Cancer Drugs in Home
-
4.4.3 Market Size and Growth Rate of Liver Cancer Drugs in Research
5 Market Analysis by Regions
-
5.1 China Liver Cancer Drugs Production Analysis by Regions
-
5.2 China Liver Cancer Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Liver Cancer Drugs Landscape Analysis
-
6.1 North China Liver Cancer Drugs Landscape Analysis by Major Types
-
6.2 North China Liver Cancer Drugs Landscape Analysis by Major End-Users
7 Central China Liver Cancer Drugs Landscape Analysis
-
7.1 Central China Liver Cancer Drugs Landscape Analysis by Major Types
-
7.2 Central China Liver Cancer Drugs Landscape Analysis by Major End-Users
8 South China Liver Cancer Drugs Landscape Analysis
-
8.1 South China Liver Cancer Drugs Landscape Analysis by Major Types
-
8.2 South China Liver Cancer Drugs Landscape Analysis by Major End-Users
9 East China Liver Cancer Drugs Landscape Analysis
-
9.1 East China Liver Cancer Drugs Landscape Analysis by Major Types
-
9.2 East China Liver Cancer Drugs Landscape Analysis by Major End-Users
10 Northeast China Liver Cancer Drugs Landscape Analysis
-
10.1 Northeast China Liver Cancer Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Liver Cancer Drugs Landscape Analysis by Major End-Users
11 Southwest China Liver Cancer Drugs Landscape Analysis
-
11.1 Southwest China Liver Cancer Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Liver Cancer Drugs Landscape Analysis by Major End-Users
12 Northwest China Liver Cancer Drugs Landscape Analysis
-
12.1 Northwest China Liver Cancer Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Liver Cancer Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Exelixis
-
13.1.1 Exelixis Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Bristol-Myers Squibb
-
13.2.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Bayer
-
13.3.1 Bayer Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Eisai
-
13.4.1 Eisai Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Merck
-
13.5.1 Merck Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Liver Cancer Drugs Market Size and Growth Rate of Targeted Therapy from 2016 to 2027
-
Figure China Liver Cancer Drugs Market Size and Growth Rate of Immunotherapy from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Liver Cancer Drugs Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Liver Cancer Drugs Market Size and Growth Rate of Home from 2016 to 2027
-
Figure China Liver Cancer Drugs Market Size and Growth Rate of Research from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Liver Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Liver Cancer Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Liver Cancer Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Liver Cancer Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Liver Cancer Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Targeted Therapy
-
Figure Market Size and Growth Rate of Immunotherapy
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Liver Cancer Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Liver Cancer Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Home
-
Figure Market Size and Growth Rate of Research
-
Table China Liver Cancer Drugs Production by Regions
-
Table China Liver Cancer Drugs Production Share by Regions
-
Figure China Liver Cancer Drugs Production Share by Regions in 2016
-
Figure China Liver Cancer Drugs Production Share by Regions in 2021
-
Figure China Liver Cancer Drugs Production Share by Regions in 2027
-
Table China Liver Cancer Drugs Consumption by Regions
-
Table China Liver Cancer Drugs Consumption Share by Regions
-
Figure China Liver Cancer Drugs Consumption Share by Regions in 2016
-
Figure China Liver Cancer Drugs Consumption Share by Regions in 2021
-
Figure China Liver Cancer Drugs Consumption Share by Regions in 2027
-
Table North China Liver Cancer Drugs Consumption by Types from 2016 to 2027
-
Table North China Liver Cancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Liver Cancer Drugs Consumption Share by Types in 2016
-
Figure North China Liver Cancer Drugs Consumption Share by Types in 2021
-
Figure North China Liver Cancer Drugs Consumption Share by Types in 2027
-
Table North China Liver Cancer Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Liver Cancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Liver Cancer Drugs Consumption Share by End-Users in 2016
-
Figure North China Liver Cancer Drugs Consumption Share by End-Users in 2021
-
Figure North China Liver Cancer Drugs Consumption Share by End-Users in 2027
-
Table Central China Liver Cancer Drugs Consumption by Types from 2016 to 2027
-
Table Central China Liver Cancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Liver Cancer Drugs Consumption Share by Types in 2016
-
Figure Central China Liver Cancer Drugs Consumption Share by Types in 2021
-
Figure Central China Liver Cancer Drugs Consumption Share by Types in 2027
-
Table Central China Liver Cancer Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Liver Cancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Liver Cancer Drugs Consumption Share by End-Users in 2016
-
Figure Central China Liver Cancer Drugs Consumption Share by End-Users in 2021
-
Figure Central China Liver Cancer Drugs Consumption Share by End-Users in 2027
-
Table South China Liver Cancer Drugs Consumption by Types from 2016 to 2027
-
Table South China Liver Cancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Liver Cancer Drugs Consumption Share by Types in 2016
-
Figure South China Liver Cancer Drugs Consumption Share by Types in 2021
-
Figure South China Liver Cancer Drugs Consumption Share by Types in 2027
-
Table South China Liver Cancer Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Liver Cancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Liver Cancer Drugs Consumption Share by End-Users in 2016
-
Figure South China Liver Cancer Drugs Consumption Share by End-Users in 2021
-
Figure South China Liver Cancer Drugs Consumption Share by End-Users in 2027
-
Table East China Liver Cancer Drugs Consumption by Types from 2016 to 2027
-
Table East China Liver Cancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Liver Cancer Drugs Consumption Share by Types in 2016
-
Figure East China Liver Cancer Drugs Consumption Share by Types in 2021
-
Figure East China Liver Cancer Drugs Consumption Share by Types in 2027
-
Table East China Liver Cancer Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Liver Cancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Liver Cancer Drugs Consumption Share by End-Users in 2016
-
Figure East China Liver Cancer Drugs Consumption Share by End-Users in 2021
-
Figure East China Liver Cancer Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Liver Cancer Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Liver Cancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Liver Cancer Drugs Consumption Share by Types in 2016
-
Figure Northeast China Liver Cancer Drugs Consumption Share by Types in 2021
-
Figure Northeast China Liver Cancer Drugs Consumption Share by Types in 2027
-
Table Northeast China Liver Cancer Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Liver Cancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Liver Cancer Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Liver Cancer Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Liver Cancer Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Liver Cancer Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Liver Cancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Liver Cancer Drugs Consumption Share by Types in 2016
-
Figure Southwest China Liver Cancer Drugs Consumption Share by Types in 2021
-
Figure Southwest China Liver Cancer Drugs Consumption Share by Types in 2027
-
Table Southwest China Liver Cancer Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Liver Cancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Liver Cancer Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Liver Cancer Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Liver Cancer Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Liver Cancer Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Liver Cancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Liver Cancer Drugs Consumption Share by Types in 2016
-
Figure Northwest China Liver Cancer Drugs Consumption Share by Types in 2021
-
Figure Northwest China Liver Cancer Drugs Consumption Share by Types in 2027
-
Table Northwest China Liver Cancer Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Liver Cancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Liver Cancer Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Liver Cancer Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Liver Cancer Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Exelixis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Exelixis
-
Figure Sales and Growth Rate Analysis of Exelixis
-
Figure Revenue and Market Share Analysis of Exelixis
-
Table Product and Service Introduction of Exelixis
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Eisai
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai
-
Figure Sales and Growth Rate Analysis of Eisai
-
Figure Revenue and Market Share Analysis of Eisai
-
Table Product and Service Introduction of Eisai
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
